{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:37:32Z","timestamp":1790696252089,"version":"4.1.0"},"reference-count":16,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T00:00:00Z","timestamp":1590019200000},"content-version":"unspecified","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012051","name":"Lupus Research Alliance","doi-asserted-by":"publisher","award":["519414"],"award-info":[{"award-number":["519414"]}],"id":[{"id":"10.13039\/100012051","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Lupus Sci Med"],"accepted":{"date-parts":[[2020,5,1]]},"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Neutrophils contribute to the SLE pathogenesis. Neutrophil to lymphocyte ratio (NLR) is reported to correlate with disease activity in SLE. The aim of the study was to evaluate whether NLR reflects underlying immunopathogenic activity in SLE, as well as to determine the contribution of each component of NLR, neutrophil and lymphocyte count.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Data were obtained from a cohort of patients with SLE (n=141) recruited at Lund University, Sweden. NLR levels were compared between patients with SLE and healthy controls (n=79). The relationship between NLR and clinical and immunological markers was examined using Mann-Whitney U test and logistic regression analysis. High NLR was defined as above the 90th percentile of healthy individuals.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Patients with SLE had elevated neutrophil count (p=0.04) and reduced lymphocyte count (p&lt;0.0001), resulting in elevated NLR as compared with healthy controls (p&lt;0.0001). Patients with high NLR had more active disease, and were more frequently on prednisone use and immunosuppressive medicines. High NLR was associated with immune complex (IC)-driven disease with presence of antidouble-stranded DNA antibodies (p=0.006), circulating ICs (p=0.02) and type I interferon (IFN) activity (p=0.009). Further, high NLR was associated with neutrophil abnormalities, including enrichment for low-density granulocytes (LDGs) (p=0.001), and increased levels of the serum neutrophil activation marker, calprotectin (p=0.02). Assessing the individual components within NLR, that is, neutrophil and lymphocyte count, high neutrophil count was associated with neutrophil activation markers (p&lt;0.0001), whereas low lymphocyte count was associated with type I IFN activity and elevated numbers of LDGs (p=0.006\u2009and p=0.001, respectively).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>NLR is elevated in patients with SLE as compared with healthy individuals, and is associated with key immunopathological events, including type I IFN activity and neutrophil activation. Neutrophil and lymphocyte count reflected different aspects of the pathogenesis of SLE. Further studies are needed to determine the causality of the associations.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/lupus-2020-000382","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T05:25:54Z","timestamp":1590125154000},"page":"e000382","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":41,"title":["Neutrophil and lymphocyte counts are associated with different immunopathological mechanisms in systemic lupus erythematosus"],"prefix":"10.1136","volume":"7","author":[{"given":"Bobby Kwanghoon","family":"Han","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Rheumatology, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine D","family":"Wysham","sequence":"additional","affiliation":[{"name":"Rheumatology Section, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C","family":"Cain","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Office for Nursing Research, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Tyden","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders A","family":"Bengtsson","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6171-1952","authenticated-orcid":false,"given":"Christian","family":"Lood","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Rheumatology, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,5,21]]},"reference":[{"key":"2025091514173802000_7.1.e000382.1","first-page":"25","article-title":"Presentation of two bone marrow elements; the tart cell and the L.E. cell","volume":"23","author":"Hargraves","year":"1948","journal-title":"Proc Staff Meet Mayo Clin"},{"key":"2025091514173802000_7.1.e000382.2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1092385"},{"key":"2025091514173802000_7.1.e000382.3","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20161512"},{"key":"2025091514173802000_7.1.e000382.4","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902199"},{"key":"2025091514173802000_7.1.e000382.5","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4027"},{"key":"2025091514173802000_7.1.e000382.6","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3001201"},{"key":"2025091514173802000_7.1.e000382.7","doi-asserted-by":"publisher","DOI":"10.1172\/JCI67390"},{"key":"2025091514173802000_7.1.e000382.8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/0961203316655208","article-title":"Pro-Inflammatory S100 proteins are associated with glomerulonephritis and anti-dsDNA antibodies in systemic lupus erythematosus","volume":"26","author":"Tyd\u00e9n","year":"2017","journal-title":"Lupus"},{"key":"2025091514173802000_7.1.e000382.9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker282"},{"key":"2025091514173802000_7.1.e000382.10","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2015.1091136"},{"key":"2025091514173802000_7.1.e000382.11","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.intimp.2016.04.006","article-title":"Neutrophil-To-Lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were associated with disease activity in patients with systemic lupus erythematosus","volume":"36","author":"Wu","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"2025091514173802000_7.1.e000382.12","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1002\/art.39656","article-title":"Platelet-Derived S100A8\/A9 and cardiovascular disease in systemic lupus erythematosus","volume":"68","author":"Lood","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2025091514173802000_7.1.e000382.13","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/art.40653","article-title":"Stratification of systemic lupus erythematosus patients into three groups of disease activity progression according to longitudinal gene expression","volume":"70","author":"Toro-Dom\u00ednguez","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2025091514173802000_7.1.e000382.14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302112"},{"key":"2025091514173802000_7.1.e000382.15","doi-asserted-by":"publisher","DOI":"10.1186\/ar3314"},{"key":"2025091514173802000_7.1.e000382.16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029333"}],"container-title":["Lupus Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/lupus-2020-000382","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T21:17:46Z","timestamp":1757971066000},"score":1,"resource":{"primary":{"URL":"https:\/\/lupus.bmj.com\/lookup\/doi\/10.1136\/lupus-2020-000382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,5,21]]},"published-print":{"date-parts":[[2020,5]]}},"alternative-id":["10.1136\/lupus-2020-000382"],"URL":"https:\/\/doi.org\/10.1136\/lupus-2020-000382","relation":{},"ISSN":["2053-8790"],"issn-type":[{"value":"2053-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}